株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

人工多能性幹細胞(iPS細胞)の世界市場:市場規模、情勢、予測 2019年~2025年

Global Induced Pluripotent Stem Cells Market Size, Status and Forecast 2019-2025

発行 QYResearch 商品コード 797011
出版日 ページ情報 英文 102 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.13円で換算しております。
Back to Top
人工多能性幹細胞(iPS細胞)の世界市場:市場規模、情勢、予測 2019年~2025年 Global Induced Pluripotent Stem Cells Market Size, Status and Forecast 2019-2025
出版日: 2019年08月28日 ページ情報: 英文 102 Pages
概要

世界の人工多能性幹細胞(iPS細胞)市場は、2018年に7,170万米ドルと評価され、2019年から2025年までに12.23%のCAGRで推移し、2025年までに1億6,090万米ドル規模の市場に成長すると予測されています。

当レポートでは、世界の人工多能性幹細胞(iPS細胞)市場を調査し、市場の概要、タイプ・用途・国別の市場規模の推移と予測、市場シェア、主要企業の収益額、市場成長の動向、主要企業のプロファイルなどをまとめています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場セグメント
  • 調査対象企業
  • 市場分析:タイプ別
  • 市場分析:用途別
  • 調査目的
  • 調査対象期間

第2章 成長動向

  • 市場規模
  • 成長動向:地域別
    • 市場規模:地域別
    • 市場シェア:地域別

第3章 主要企業の市場占有率

  • 市場規模:企業別
    • 収益額:企業別
    • 収益シェア:企業別
    • 市場集中度
  • 主要企業の生産拠点と事業エリア
  • 合併・買収・拡大計画

第4章 市場の内訳:タイプ・用途別

  • 市場規模:タイプ別(実績値)
  • 市場規模:用途別(実績値)

第5章 米国

  • 米国の人工多能性幹細胞(iPS細胞)市場
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第6章 欧州

  • 欧州の人工多能性幹細胞(iPS細胞)市場
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第7章 中国

  • 中国の人工多能性幹細胞(iPS細胞)市場
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第8章 日本

  • 日本の人工多能性幹細胞(iPS細胞)市場
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第9章 東南アジア

  • 東南アジアの人工多能性幹細胞(iPS細胞)市場
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第10章 インド

  • インドの人工多能性幹細胞(iPS細胞)市場
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第11章 中南米

  • 中南米の人工多能性幹細胞(iPS細胞)市場
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第12章 主要企業のプロファイル

  • 富士フイルムホールディングス
  • Ncardia
  • 大日本住友製薬
  • アステラス製薬
  • Fate Therapeutics, Inc.
  • Pluricell Biotech
  • Cell Inspire Biotechnology
  • ReproCELL

第13章 市場予測

  • 市場規模の推移と予測
  • 米国
  • 欧州
  • 中国
  • 日本
  • 東南アジア
  • インド
  • 中南米
  • 市場規模の予測:製品別
  • 市場規模の予測:用途別

第14章 アナリストの考察と総論

第15章 付録

  • 調査方法
  • 免責事項
  • 著者について
図表

List of Tables and Figures

  • Table Induced Pluripotent Stem Cells Key Market Segments
  • Table Induced Pluripotent Stem Cells Key Players Covered in 2018
  • Table Global Induced Pluripotent Stem Cells Market Size Growth Rate by Type (2014-2025) (Million US$)
  • Figure Global Induced Pluripotent Stem Cells Market Share by Type in 2018 & 2025
  • Table Global Induced Pluripotent Stem Cells Market Size Growth by Application (2019-2025) (Million US$)
  • Figure Global Induced Pluripotent Stem Cells Market Share by Application in 2018 & 2025
  • Figure Induced Pluripotent Stem Cells Report Years Considered
  • Figure Global Induced Pluripotent Stem Cells Market Size and Growth Rate 2014-2025 (Million US$)
  • Table Global Induced Pluripotent Stem Cells Market Size by Regions 2019-2025 (Million US$)
  • Figure Global Induced Pluripotent Stem Cells Market Size by Regions 2019-2025 (Million US$)
  • Table Global Induced Pluripotent Stem Cells Market Size by Regions 2014-2019 (Million US$)
  • Table Global Induced Pluripotent Stem Cells Market Share by Regions 2014-2019
  • Figure Global Induced Pluripotent Stem Cells Market Share by Regions 2014-2019
  • Figure Global Induced Pluripotent Stem Cells Market Share by Regions 2018
  • Table Global Induced Pluripotent Stem Cells Revenue by Players (2014-2019) (Million US$)
  • Table Global Induced Pluripotent Stem Cells Market Share by Players (2014-2019)
  • Figure Global Induced Pluripotent Stem Cells Market Share by Players in 2018
  • Table Global Induced Pluripotent Stem Cells Manufacturers Market Concentration Ratio (CR5)
  • Table Key Players Head office and Area Served
  • Table Global Induced Pluripotent Stem Cells Market Size by Type (2014-2019) (Million US$)
  • Table Global Induced Pluripotent Stem Cells Market Size Share by Type (2014-2019)
  • Figure Global Induced Pluripotent Stem Cells Market Size Market Share by Type (2014-2019)
  • Table Global Induced Pluripotent Stem Cells Market Size by Application (2014-2019) (Million US$)
  • Table Global Induced Pluripotent Stem Cells Market Size Share by Application (2014-2019)
  • Figure Global Induced Pluripotent Stem Cells Market Size Market Share by Application (2014-2019)
  • Figure Global Induced Pluripotent Stem Cells Revenue Market Share by Application in 2018
  • Figure United States Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$)
  • Table United States Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$)
  • Figure United States Key Players Induced Pluripotent Stem Cells Market Share in 2019
  • Figure United States Induced Pluripotent Stem Cells Market Share by Type in 2018
  • Figure United States Induced Pluripotent Stem Cells Market Share by Application in 2018
  • Figure Europe Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$)
  • Table Europe Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$)
  • Table Europe Key Players Induced Pluripotent Stem Cells Market Share in 2019
  • Figure Europe Induced Pluripotent Stem Cells Market Share by Type in 2018
  • Figure Europe Induced Pluripotent Stem Cells Market Share by Application in 2018
  • Figure China Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$)
  • Table China Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$)
  • Figure China Key Players Induced Pluripotent Stem Cells Market Share in 2019
  • Figure China Induced Pluripotent Stem Cells Market Share by Type in 2018
  • Figure China Induced Pluripotent Stem Cells Market Share by Application in 2018
  • Figure Japan Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$)
  • Table Japan Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$)
  • Figure Japan Key Players Induced Pluripotent Stem Cells Market Share in 2019
  • Figure Japan Induced Pluripotent Stem Cells Market Share by Type in 2018
  • Figure Japan Induced Pluripotent Stem Cells Market Share by Application in 2018
  • Figure Southeast Asia Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$)
  • Table Southeast Asia Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$)
  • Figure Southeast Asia Key Players Induced Pluripotent Stem Cells Market Share in 2019
  • Figure Southeast Asia Induced Pluripotent Stem Cells Market Share by Type in 2018
  • Figure Southeast Asia Induced Pluripotent Stem Cells Market Share by Application in 2018
  • Figure India Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$)
  • Table India Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$)
  • Figure India Key Players Induced Pluripotent Stem Cells Market Share in 2019
  • Figure India Induced Pluripotent Stem Cells Market Share by Type in 2018
  • Figure India Induced Pluripotent Stem Cells Market Share by Application in 2018
  • Figure Central & South America Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$)
  • Table Central & South America Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$)
  • Figure Central & South America Key Players Induced Pluripotent Stem Cells Market Share in 2019
  • Figure Central & South America Induced Pluripotent Stem Cells Market Share by Type in 2018
  • Figure Central & South America Induced Pluripotent Stem Cells Market Share by Application in 2018
  • Table Fujifilm Holding Corporation (CDI) Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Figure Induced Pluripotent Stem Cells Product Picture Examples of Fujifilm Holding Corporation (CDI)
  • Table Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells Business (2014-2019) (Million US$)
  • Figure Fujifilm Holding Corporation (CDI) Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
  • Figure Fujifilm Holding Corporation (CDI) Revenue Share in Induced Pluripotent Stem Cells Business (2014-2019)
  • Table Ncardia Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Figure Induced Pluripotent Stem Cells Product Picture Examples of Ncardia
  • Table Ncardia Revenue in Induced Pluripotent Stem Cells Business (2014-2019) (Million US$)
  • Figure Ncardia Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
  • Figure Ncardia Revenue Share in Induced Pluripotent Stem Cells Business (2014-2019)
  • Table Sumitomo Dainippon Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Figure Induced Pluripotent Stem Cells Product Picture Examples of Sumitomo Dainippon Pharma
  • Table Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells Business (2014-2019) (Million US$)
  • Figure Sumitomo Dainippon Pharma Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
  • Figure Sumitomo Dainippon Pharma Revenue Share in Induced Pluripotent Stem Cells Business (2014-2019)
  • Table Astellas Pharma Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Astellas Pharma Inc. Revenue in Induced Pluripotent Stem Cells Business (2014-2019) (Million US$)
  • Figure Astellas Pharma Inc. Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
  • Figure Astellas Pharma Inc. Revenue Share in Induced Pluripotent Stem Cells Business (2014-2019)
  • Table Fate Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Figure Induced Pluripotent Stem Cells Product Picture Examples of Fate Therapeutics, Inc.
  • Table Fate Therapeutics, Inc. Revenue in Induced Pluripotent Stem Cells Business (2014-2019) (Million US$)
  • Figure Fate Therapeutics, Inc. Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
  • Figure Fate Therapeutics, Inc. Revenue Share in Induced Pluripotent Stem Cells Business (2014-2019)
  • Table Pluricell Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Figure Induced Pluripotent Stem Cells Product Picture Examples of Pluricell Biotech
  • Table Pluricell Biotech Revenue in Induced Pluripotent Stem Cells Business (2014-2019) (Million US$)
  • Figure Pluricell Biotech Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
  • Figure Pluricell Biotech Revenue Share in Induced Pluripotent Stem Cells Business (2014-2019)
  • Table Cell Inspire Biotechnology Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Figure Induced Pluripotent Stem Cells Product Specification Examples of Cell Inspire Biotechnology
  • Table Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells Business (2014-2019) (Million US$)
  • Figure Cell Inspire Biotechnology Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
  • Figure Cell Inspire Biotechnology Revenue Share in Induced Pluripotent Stem Cells Business (2014-2019)
  • Table ReproCELL Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Figure Induced Pluripotent Stem Cells Product Picture Examples of ReproCELL
  • Figure Induced Pluripotent Stem Cells Product Specification Examples of ReproCELL
  • Table ReproCELL Revenue in Induced Pluripotent Stem Cells Business (2014-2019) (Million US$)
  • Figure ReproCELL Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
  • Figure ReproCELL Revenue Share in Induced Pluripotent Stem Cells Business (2014-2019)
  • Table Global Induced Pluripotent Stem Cells Market Size by Regions (Million US$) 2019-2025
  • Figure Global Induced Pluripotent Stem Cells Market Size Share by Regions (2019-2025)
  • Figure Global Induced Pluripotent Stem Cells Market Size Share by Regions in 2025
  • Figure United States Induced Pluripotent Stem Cells Market Size Forecast (2019-2025) (Million USD)
  • Figure Europe Induced Pluripotent Stem Cells Market Size Forecast (2019-2025) (Million USD)
  • Figure China Induced Pluripotent Stem Cells Market Size Forecast (2019-2025) (Million USD)
  • Figure Japan Induced Pluripotent Stem Cells Market Size Forecast (2019-2025) (Million USD)
  • Figure Southeast Asia Induced Pluripotent Stem Cells Market Size Forecast (2019-2025) (Million USD)
  • Figure India Induced Pluripotent Stem Cells Market Size Forecast (2019-2025) (Million USD)
  • Figure Central & South America Induced Pluripotent Stem Cells Market Size Forecast (2019-2025) (Million USD)
  • Table Global Induced Pluripotent Stem Cells Market Size by Product (2019-2025) (Million USD)
  • Figure Global Induced Pluripotent Stem Cells Market Size by Product (2019-2025)
  • Figure Global Induced Pluripotent Stem Cells Market Size by Product in 2025
  • Table Global Induced Pluripotent Stem Cells Market Size by Application (w (Million USD)
  • Figure Global Induced Pluripotent Stem Cells Market Size by Application (2019-2025)
  • Figure Global Induced Pluripotent Stem Cells Market Size by Application in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Figure Key Executives Interviewed
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
目次

In 2018, the global Induced Pluripotent Stem Cells market size was 71.7 million US$ and it is expected to reach 160.9 million US$ by the end of 2025, with a CAGR of 12.23% during 2019-2025.

This report focuses on the global Induced Pluripotent Stem Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Induced Pluripotent Stem Cells development in United States, Europe, China, Japan, Southeast Asia, India, Central & South America and Other Regions

The key players covered in this study:

  • Fujifilm Holding Corporation (CDI)
  • Ncardia
  • Sumitomo Dainippon Pharma
  • Astellas Pharma Inc
  • Fate Therapeutics, Inc
  • Pluricell Biotech
  • Cell Inspire Biotechnology
  • ReproCELL

Market segment by Type, the product can be split into:

  • Human iPSCs
  • Mouse iPSCs

Market segment by Application, split into:

  • Academic Research
  • Drug Development and Discovery
  • Toxicity Screening
  • Regenerative Medicine
  • Others

Market segment by Regions/Countries, this report covers:

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
  • Other Regions

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered
  • 1.4 Market Analysis by Type
  • 1.5 Market by Application
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Induced Pluripotent Stem Cells Market Size
  • 2.2 Induced Pluripotent Stem Cells Growth Trends by Regions
    • 2.2.1 Induced Pluripotent Stem Cells Market Size by Regions (2019-2025)
    • 2.2.2 Induced Pluripotent Stem Cells Market Share by Regions (2014-2019)

3 Market Share by Key Players

  • 3.1 Induced Pluripotent Stem Cells Market Size by Players
    • 3.1.1 Global Induced Pluripotent Stem Cells Revenue by Players (2014-2019)
    • 3.1.2 Global Induced Pluripotent Stem Cells Revenue Market Share by Players (2014-2019)
    • 3.1.3 Global Induced Pluripotent Stem Cells Market Concentration Ratio (CR5)
  • 3.2 Induced Pluripotent Stem Cells Key Players Manufacturing Sites and Area Served
  • 3.3 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

  • 4.1 Global Induced Pluripotent Stem Cells Market Size by Type (2014-2019)
  • 4.2 Global Induced Pluripotent Stem Cells Market Size by Application (2014-2019)

5 United States

  • 5.1 United States Induced Pluripotent Stem Cells Market (2014-2019)
  • 5.2 Induced Pluripotent Stem Cells Key Players in United States
  • 5.3 United States Induced Pluripotent Stem Cells Market Size by Type
  • 5.4 United States Induced Pluripotent Stem Cells Market Size by Application

6 Europe

  • 6.1 Europe Induced Pluripotent Stem Cells Market (2014-2019)
  • 6.2 Induced Pluripotent Stem Cells Key Players in Europe
  • 6.3 Europe Induced Pluripotent Stem Cells Market Size by Type
  • 6.4 Europe Induced Pluripotent Stem Cells Market Size by Application

7 China

  • 7.1 China Induced Pluripotent Stem Cells Market (2014-2019)
  • 7.2 Induced Pluripotent Stem Cells Key Players in China
  • 7.3 China Induced Pluripotent Stem Cells Market Size by Type
  • 7.4 China Induced Pluripotent Stem Cells Market Size by Application

8 Japan

  • 8.1 Japan Induced Pluripotent Stem Cells Market (2014-2019)
  • 8.2 Induced Pluripotent Stem Cells Key Players in Japan
  • 8.3 Japan Induced Pluripotent Stem Cells Market Size by Type
  • 8.4 Japan Induced Pluripotent Stem Cells Market Size by Application

9 Southeast Asia

  • 9.1 Southeast Asia Induced Pluripotent Stem Cells Market (2014-2019)
  • 9.2 Induced Pluripotent Stem Cells Key Players in Southeast Asia
  • 9.3 Southeast Asia Induced Pluripotent Stem Cells Market Size by Type
  • 9.4 Southeast Asia Induced Pluripotent Stem Cells Market Size by Application

10 India

  • 10.1 India Induced Pluripotent Stem Cells Market (2014-2019)
  • 10.2 Induced Pluripotent Stem Cells Key Players in India
  • 10.3 India Induced Pluripotent Stem Cells Market Size by Type
  • 10.4 India Induced Pluripotent Stem Cells Market Size by Application

11 Central & South America

  • 11.1 Central & South America Induced Pluripotent Stem Cells Market (2014-2019)
  • 11.2 Induced Pluripotent Stem Cells Key Players in Central & South America
  • 11.3 Central & South America Induced Pluripotent Stem Cells Market Size by Type
  • 11.4 Central & South America Induced Pluripotent Stem Cells Market Size by Application

12 Key Players Profiles

  • 12.1 Fujifilm Holding Corporation (CDI)
    • 12.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 12.1.2 Induced Pluripotent Stem Cells Product Overview
    • 12.1.3 Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
    • 12.1.4 Main Business/Business Overview
  • 12.2 Ncardia
    • 12.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 12.2.2 Induced Pluripotent Stem Cells Product Overview
    • 12.2.3 Ncardia Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
    • 12.2.4 Main Business/Business Overview
  • 12.3 Sumitomo Dainippon Pharma
    • 12.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 12.3.2 Induced Pluripotent Stem Cells Product Overview
    • 12.3.3 Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
    • 12.3.4 Main Business/Business Overview
  • 12.4 Astellas Pharma Inc.
    • 12.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 12.4.2 Induced Pluripotent Stem Cells Product Overview
    • 12.4.3 Astellas Pharma Inc. Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
    • 12.4.4 Main Business/Business Overview
  • 12.5 Fate Therapeutics, Inc.
    • 12.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 12.5.2 Induced Pluripotent Stem Cells Product Overview
    • 12.5.3 Fate Therapeutics, Inc. Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
    • 12.5.4 Main Business/Business Overview
  • 12.6 Pluricell Biotech
    • 12.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 12.6.2 Induced Pluripotent Stem Cells Product Overview
    • 12.6.3 Pluricell Biotech Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
    • 12.6.4 Main Business/Business Overview
  • 12.7 Cell Inspire Biotechnology
    • 12.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 12.7.2 Induced Pluripotent Stem Cells Product Overview
    • 12.7.3 Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
    • 12.7.4 Main Business/Business Overview
  • 12.8 ReproCELL
    • 12.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 12.8.2 Induced Pluripotent Stem Cells Product Overview
    • 12.8.3 ReproCELL Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
    • 12.8.4 Main Business/Business Overview

13 Market Forecast 2019-2025

  • 13.1 Market Size Forecast by Regions
  • 13.2 United States
  • 13.3 Europe
  • 13.4 China
  • 13.5 Japan
  • 13.6 Southeast Asia
  • 13.7 India
  • 13.8 Central & South America
  • 13.9 Market Size Forecast by Product (2019-2025)
  • 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Disclaimer
  • 15.3 Author Details
Back to Top